These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30964804)

  • 41. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.
    McCormack S; Dunn DT; Desai M; Dolling DI; Gafos M; Gilson R; Sullivan AK; Clarke A; Reeves I; Schembri G; Mackie N; Bowman C; Lacey CJ; Apea V; Brady M; Fox J; Taylor S; Antonucci S; Khoo SH; Rooney J; Nardone A; Fisher M; McOwan A; Phillips AN; Johnson AM; Gazzard B; Gill ON
    Lancet; 2016 Jan; 387(10013):53-60. PubMed ID: 26364263
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIV pre-exposure prophylaxis for female sex workers: ensuring women's family planning needs are not left behind.
    Bowring AL; Ampt FH; Schwartz S; Stoové MA; Luchters S; Baral S; Hellard M
    J Int AIDS Soc; 2020 Feb; 23(2):e25442. PubMed ID: 32064765
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhancing national prevention and treatment services for sex workers in Zimbabwe: a process evaluation of the SAPPH-IRe trial.
    Busza J; Chiyaka T; Musemburi S; Fearon E; Davey C; Chabata S; Mushati P; Dirawo J; Napierala S; Phillips AN; Cowan FM; Hargreaves JR
    Health Policy Plan; 2019 Jun; 34(5):337-345. PubMed ID: 31157368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intimate Partner Violence and Adherence to HIV Pre-exposure Prophylaxis (PrEP) in African Women in HIV Serodiscordant Relationships: A Prospective Cohort Study.
    Roberts ST; Haberer J; Celum C; Mugo N; Ware NC; Cohen CR; Tappero JW; Kiarie J; Ronald A; Mujugira A; Tumwesigye E; Were E; Irungu E; Baeten JM;
    J Acquir Immune Defic Syndr; 2016 Nov; 73(3):313-322. PubMed ID: 27243900
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services.
    Liu AY; Cohen SE; Vittinghoff E; Anderson PL; Doblecki-Lewis S; Bacon O; Chege W; Postle BS; Matheson T; Amico KR; Liegler T; Rawlings MK; Trainor N; Blue RW; Estrada Y; Coleman ME; Cardenas G; Feaster DJ; Grant R; Philip SS; Elion R; Buchbinder S; Kolber MA
    JAMA Intern Med; 2016 Jan; 176(1):75-84. PubMed ID: 26571482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HIV infection risk and condom use among sex workers in Senegal: evidence from the list experiment method.
    Lépine A; Treibich C; Ndour CT; Gueye K; Vickerman P
    Health Policy Plan; 2020 May; 35(4):408-415. PubMed ID: 32040183
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alcohol-antiretroviral interactive toxicity beliefs as a potential barrier to HIV pre-exposure prophylaxis among men who have sex with men.
    Kalichman SC; Eaton L
    J Int AIDS Soc; 2017 Jul; 20(1):21534. PubMed ID: 28715159
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of HIV prevention products on incentives to supply condomless commercial sex among female sex workers in South Africa.
    Quaife M; Vickerman P; Manian S; Eakle R; Cabrera-Escobar MA; Delany-Moretlwe S; Terris-Prestholt F
    Health Econ; 2018 Oct; 27(10):1550-1566. PubMed ID: 29926508
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Persistence on oral pre-exposure prophylaxis (PrEP) among female sex workers in eThekwini, South Africa, 2016-2020.
    Rao A; Mhlophe H; Comins C; Young K; Mcingana M; Lesko C; Mulumba N; Baral S; Hausler H; Schwartz S
    PLoS One; 2022; 17(3):e0265434. PubMed ID: 35290421
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A qualitative study to explore daily versus on-demand oral pre-exposure prophylaxis (PrEP) in young people from South Africa, Uganda and Zimbabwe.
    Dietrich JJ; Ahmed N; Tshabalala G; Wu M; Mulaudzi M; Hornschuh S; Atujuna M; Muhumuza R; Ssemata AS; Stranix-Chibanda L; Nematadzira T; Bekker LG; Martinson N; Seeley J; Fox J
    PLoS One; 2023; 18(6):e0287627. PubMed ID: 37384792
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation.
    Liu AY; Hessol NA; Vittinghoff E; Amico KR; Kroboth E; Fuchs J; Irvin R; Sineath RC; Sanchez T; Sullivan PS; Buchbinder SP
    AIDS Patient Care STDS; 2014 Dec; 28(12):622-7. PubMed ID: 25396706
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HIV self-testing and oral pre-exposure prophylaxis are empowering for sex workers and their intimate partners: a qualitative study in Uganda.
    Mujugira A; Nakyanzi A; Kasiita V; Kamusiime B; Nalukwago GK; Nalumansi A; Twesigye CC; Muwonge TR; Baeten JM; Wyatt MA; Haberer JE; Ware NC
    J Int AIDS Soc; 2021 Sep; 24(9):e25782. PubMed ID: 34473405
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost-effectiveness.
    Glaubius R; Ding Y; Penrose KJ; Hood G; Engquist E; Mellors JW; Parikh UM; Abbas UL
    J Int AIDS Soc; 2019 May; 22(5):e25282. PubMed ID: 31074936
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PrEP implementation research in Africa: what is new?
    Cowan FM; Delany-Moretlwe S; Sanders EJ; Mugo NR; Guedou FA; Alary M; Behanzin L; Mugurungi O; Bekker LG
    J Int AIDS Soc; 2016; 19(7(Suppl 6)):21101. PubMed ID: 27760680
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIV Prevention Method Preferences Within Sexual Partnerships Reported by HIV-Negative MSM and TW in Tijuana, Mexico.
    Pines HA; Patrick R; Smith DM; Harvey-Vera A; Blumenthal JS; Rangel G; Semple SJ; Patterson TL
    AIDS Behav; 2020 Mar; 24(3):839-846. PubMed ID: 30945030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differences in awareness of and willingness to use pre-exposure prophylaxis and anticipated condom use among serodiscordant couples in Taiwan.
    Ko NY; Wu HJ; Strong C; Li CW; Ku WW; Hsu ST
    AIDS Care; 2018 Oct; 30(10):1306-1310. PubMed ID: 29845871
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sexual Behavior and Perceived HIV Risk Among HIV-Negative Members of Serodiscordant Couples in East Africa.
    Wanga V; Baeten JM; Bukusi EA; Mugo NR; Asiimwe S; Ngure K; Mujugira A; Muwonge T; Odoyo JB; Haberer JE; Celum C; Heffron R;
    AIDS Behav; 2020 Jul; 24(7):2082-2090. PubMed ID: 31925607
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Effect of PrEP on HIV Incidence Among Men Who Have Sex With Men in the Context of Condom Use, Treatment as Prevention, and Seroadaptive Practices.
    LeVasseur MT; Goldstein ND; Tabb LP; Olivieri-Mui BL; Welles SL
    J Acquir Immune Defic Syndr; 2018 Jan; 77(1):31-40. PubMed ID: 28961679
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factors Associated With Sex-Related Pre-exposure Prophylaxis Adherence Among Men Who Have Sex With Men in New York City in HPTN 067.
    Mannheimer S; Hirsch-Moverman Y; Franks J; Loquere A; Hughes JP; Li M; Amico KR; Grant RM
    J Acquir Immune Defic Syndr; 2019 Apr; 80(5):551-558. PubMed ID: 30865051
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acceptability of a long-acting injectable HIV prevention product among US and African women: findings from a phase 2 clinical Trial (HPTN 076).
    Tolley EE; Li S; Zangeneh SZ; Atujuna M; Musara P; Justman J; Pathak S; Bekker LG; Swaminathan S; Stanton J; Farrior J; Sista N
    J Int AIDS Soc; 2019 Oct; 22(10):e25408. PubMed ID: 31651098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.